Mirtazapin Ct (Mirtazapine)

Mirtazapine works by blocking presynaptic α2‑adrenergic receptors, which increases the release of norepinephrine, and by antagonizing postsynaptic 5‑HT2 and 5‑HT3 receptors, enhancing serotonergic activity while reducing side effects such as anxiety and nausea.

The dosage of Mirtazapin Ct is determined by the prescribing clinician based on the individual patient's condition, response, and tolerability. Only a qualified health professional can set the appropriate dose and schedule.

Safety data for mirtazapine in pregnancy and lactation are limited. The prescriber should weigh potential benefits against possible risks and consider alternative therapies when appropriate. Women who are pregnant or nursing should discuss treatment options with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Mirtazapine belongs to the NaSSA class, differing from SSRIs and SNRIs by its dual action on norepinephrine and serotonin receptors and its strong antihistaminic effect, which often leads to sedation and weight gain. This profile can be advantageous for patients needing sleep support but may be less suitable for those concerned about metabolic side effects.

Mirtazapin Ct should be stored below 25 °C in its original packaging, protected from moisture and direct sunlight. Maintaining a stable, room‑temperature environment helps preserve the tablet’s potency and integrity throughout its shelf life.

Mirtazapin Ct is taken orally, usually once daily in the evening to take advantage of its sedative properties. The tablet should be swallowed whole with water and not chewed or crushed unless specifically directed by a healthcare professional.

Serious risks include the potential for agranulocytosis, severe hepatic dysfunction, seizures, and the emergence of suicidal thoughts, particularly during the initial treatment phase. Prompt medical attention is required if any of these symptoms occur.

Mirtazapin Ct is contraindicated in patients with known hypersensitivity to mirtazapine or any of its excipients, and it should be avoided in individuals currently taking monoamine oxidase inhibitors. Caution is also advised for patients with severe liver impairment or a history of blood dyscrasias.